Sickle cell pain management: are we missing the role of pronociception and neuropathic pain?
- 1 October 2013
- journal article
- other
- Published by Wiley in Pediatric Anesthesia
- Vol. 23 (11) , 1104-1105
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Low‐dose ketamine as a potential adjuvant therapy for painful vaso‐occlusive crises in sickle cell diseasePediatric Anesthesia, 2013
- Continuous Intravenous Infusion of Ketamine and Lidocaine as Adjuvant Analgesics in a 5-Year-Old Patient with Neuropathic Cancer PainJournal of Palliative Medicine, 2012
- Update on Pain Management in Sickle Cell DiseaseHemoglobin, 2011
- Neurobiological Mechanisms of Pain in Sickle Cell DiseaseHematology-American Society Hematology Education Program, 2010
- Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatmentThe Lancet Neurology, 2010
- Transition from acute to chronic postsurgical pain: risk factors and protective factorsExpert Review of Neurotherapeutics, 2009
- Epidural analgesia in a child with sickle cell disease complicated by acute abdominal pain and priapismBritish Journal of Anaesthesia, 2001
- Preserved Acute Pain and Reduced Neuropathic Pain in Mice Lacking PKCγScience, 1997
- Epidural Analgesia in the Management of Severe Vaso-Occlusive Sickle Cell CrisisPediatrics, 1994